Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 13/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.40 |
| ▸ | FAP | Q12884 | 3/20 | 0.40 |
| ▸ | PREP | P48147 | 2/20 | 0.40 |
| ▸ | PITRM1 | Q5JRX3 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6600988 | 1.00 | L3MBTL3 (0.47) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL4678731 | 0.98 | L3MBTL3 (0.46) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL6601198 | 0.98 | L3MBTL3 (0.46) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL4679624 | 0.98 | L3MBTL3 (0.46) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL6368323 | 0.98 | L3MBTL3 (0.46) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL5144762 | 0.88 | L3MBTL3 (0.45) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| SCHEMBL5891871 | 0.87 | L3MBTL3 (0.49) | L3MBTL3L3MBTL1DPP4DPP7DPP8 | |
| SCHEMBL4678714 | 0.85 | DPP4 (0.55) | DPP4DPP7DPP8DPP9 | |
| SCHEMBL6600066 | 0.85 | DPP4 (0.55) | DPP4DPP7DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL5142506 | 0.84 | L3MBTL3 (0.42) | L3MBTL3L3MBTL1DPP4DPP7DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1409479-B1 | 1-GLYCINYL-4-(1-METHYLPIPERIDIN-4-YL)PIPERAZINES AND -PIPERIDINES AS FACTOR XA ANTAGONISTS | LILLY CO ELI (US) | 2008-01-23 | — | — | EP | disclosed |
| US-7265121-B2 | Chemical compounds | ELI LILLY AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-20050026928-A1 | Chemical compounds | ELI LILLY AND COMPANY | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026928-A1 | Chemical compounds | F2, F12, F11 | L3MBTL3 1489/4885L3MBTL1 961/4885DPP4 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.